1-10 of 10
Robert Wechsler-Reya
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4304: Network-based inference identifies cell state-specific drugs targeting master regulator vulnerabilities in diffuse midline glioma

Ester Calvo Fernandez, Junqiang Wang, Xu Zhang, Hong-Jian Wei, Hanna E. Minns, Aaron T. Griffin, Lukas Vlahos, Timothy J. Martins, Pamela S. Becker, John Crawford, Robyn D. Gartrell, Luca Szalontay, Stergios Zacharoulis, Zhiguo Zhang, Robert Wechsler-Reya, Cheng-Chia Wu, Andrea Califano, Jovana Pavisic
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4304.
https://doi.org/10.1158/1538-7445.AM2023-4304
Published: 04 April 2023
View article titled, Abstract 4304: Network-based inference identifies cell state-specific drugs targeting master regulator vulnerabilities in diffuse midline glioma
Journal Articles

N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma

Duygu Kuzuoglu-Ozturk, Ozlem Aksoy, Christin Schmidt, Robin Lea, Jon D. Larson, Ryan R.L. Phelps, Nicole Nasholm, Megan Holt, Adrian Contreras, Miller Huang, Shannon Wong-Michalak, Hao Shao, Robert Wechsler-Reya, Joanna J. Phillips, Jason E. Gestwicki, Davide Ruggero, William A. Weiss
Journal: Cancer Research
Cancer Res (2023) 83 (1): 130–140.
https://doi.org/10.1158/0008-5472.CAN-22-0945
Published: 04 January 2023
View article titled, N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
Open the PDF for N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma in another window
Includes: Supplementary data
Journal Articles

Abstract 5688: IND-enabling characterization of ONC206 as the next bitopic antagonist for oncology

Varun Vijay Prabhu, Sara Morrow, Caroline A. Cuoco, Abed R. Kawakibi, Jinkyu Jung, Neel Madhukar, Matthew J. Garnett, Ultan McDermott, Cyril H. Benes, Robert Wechsler-Reya, Lakshmi Anantharaman, Neil Charter, Joseph B. Rucker, Benjamin J. Doranz, Joel Basken, Olivier Elemento, R. Benjamin Free, David R. Sibley, Martin Stogniew, Wolfgang Oster, Mark R. Gilbert, Sharon DeMorrow
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 5688.
https://doi.org/10.1158/1538-7445.AM2020-5688
Published: 15 August 2020
View article titled, Abstract 5688: IND-enabling characterization of ONC206 as the next bitopic antagonist for oncology
Journal Articles

Abstract B21: Childhood Cancer Molecular Map (C2M2) to define medulloblastoma heterogeneity and predict treatment response

Huwate Yeerna, Benjamin Briggs, Jessica Rusert, Lukas Chavez, Jill Mesirov, Robert Wechsler-Reya, Pablo Tamayo
Journal: Cancer Research
Cancer Res (2020) 80 (14_Supplement): B21.
https://doi.org/10.1158/1538-7445.PEDCA19-B21
Published: 15 July 2020
View article titled, Abstract B21: Childhood Cancer Molecular Map (C2M2) to define medulloblastoma heterogeneity and predict treatment response
Journal Articles

Abstract 263: KITlow cells mediate Imatinib resistance and disease persistence in gastrointestinal stromal tumor

Sudeep Banerjee, Chih-Min Tang, Mayra Yebra, Kwat Medetgul, Adam M. Burgoyne, Pablo Tamayo, Robert Wechsler-Reya, Jason K. Sicklick
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 263.
https://doi.org/10.1158/1538-7445.AM2019-263
Published: 01 July 2019
View article titled, Abstract 263: KIT<sup>low</sup> cells mediate Imatinib resistance and disease persistence in gastrointestinal stromal tumor
Journal Articles

Abstract 3877: IND-enabling characterization of DRD2/3 imipridone antagonist ONC206 for oncology

Varun V. Prabhu, Abed Rahman Kawakibi, Neel Madhukar, Mathew J. Garnett, Ultan McDermott, Cyril H. Benes, Lakshmi Anantharaman, Neil Charter, Sean Deacon, Alexander VanEngelenburg, Joseph B. Rucker, Benjamin J. Doranz, Jessica Rusert, Robert Wechsler-Reya, Olivier Elemento, Martin Stogniew, Wolfgang Oster, Sharon DeMorrow, R. Benjamin Free, David R. Sibley, Joshua E. Allen
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3877.
https://doi.org/10.1158/1538-7445.AM2019-3877
Published: 01 July 2019
View article titled, Abstract 3877: IND-enabling characterization of DRD2/3 imipridone antagonist ONC206 for oncology
Journal Articles

Abstract 3448: Subtypes of medulloblastoma have distinct developmental origins

Paul Gibson, Yiai Tong, Giles Robinson, Helen Poppleton, Margaret C. Thompson, David S. Currle, Christopher Eden, Twala L. Hogg, David Finkelstein, Stanley Pounds, Zoltan Patay, Matthew Scoggins, Yanxin Pei, Robert Ogg, Youngsoo Lee, Frederique Zindy, Janet C. Lindsey, Frederic A. Boop, Amar Gajjar, Steven C. Clifford, Martine F. Roussel, Peter J. McKinnon, David W. Ellison, Robert Wechsler-Reya, David H. Gutmann, Richard J. Gilbertson
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3448.
https://doi.org/10.1158/1538-7445.AM2011-3448
Published: 15 April 2011
View article titled, Abstract 3448: Subtypes of medulloblastoma have distinct developmental origins
Journal Articles

Abstract 3443: Targeting G2/M cell cycle regulators in medulloblastoma tumor-propagating cells

Shirley L. Markant, Kelly Barton, Jesse Sun, Robert Wechsler-Reya
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3443.
https://doi.org/10.1158/1538-7445.AM2011-3443
Published: 15 April 2011
View article titled, Abstract 3443: Targeting G2/M cell cycle regulators in medulloblastoma tumor-propagating cells
Journal Articles

The Putative Tumor Suppressor BIN1 Is a Short-Lived Nuclear Phosphoprotein, the Localization of Which Is Altered in Malignant Cells

Robert Wechsler-Reya, Katherine Elliott, Meenhard Herlyn, George C. Prendergast
Journal: Cancer Research
Cancer Res (1997) 57 (15): 3258–3263.
Published: 01 August 1997
View article titled, The Putative Tumor Suppressor BIN1 Is a Short-Lived Nuclear Phosphoprotein, the Localization of Which Is Altered in Malignant Cells
Open the PDF for The Putative Tumor Suppressor BIN1 Is a Short-Lived Nuclear Phosphoprotein, the Localization of Which Is Altered in Malignant Cells in another window
Journal Articles

Resistance of a Variant ras-transformed Cell Line to Phenotypic Reversion by Farnesyl Transferase Inhibitors

George C. Prendergast, Joseph P. Davide, Peter F. Lebowitz, Robert Wechsler-Reya, Nancy E. Kohl
Journal: Cancer Research
Cancer Res (1996) 56 (11): 2626–2632.
Published: 01 June 1996
View article titled, Resistance of a Variant <em>ras</em>-transformed Cell Line to Phenotypic Reversion by Farnesyl Transferase Inhibitors
Open the PDF for Resistance of a Variant <em>ras</em>-transformed Cell Line to Phenotypic Reversion by Farnesyl Transferase Inhibitors in another window